Discontinued — last reported Q2 '25
STERIS Life Science Member — Revenue decreased by 9.5% to $135.20M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.2%, from $128.50M to $135.20M. Over 2 years (FY 2023 to FY 2025), Life Science Member — Revenue shows relatively stable performance with a 0.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growing demand for sterilization and contamination control solutions within the pharmaceutical and biotech sectors.
This metric represents the total revenue generated by the Life Science business segment, which provides specialized ster...
Comparable to revenue metrics for specialized life science equipment and service divisions at other medical technology or industrial sterilization firms.
ste_segment_life_science_member_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $121.47M | $132.33M | $127.91M | $132.21M | $125.77M | $121.27M | $157.46M | $131.41M | $133.10M | $146.57M | $160.63M | $128.50M | $127.95M | $136.38M | $149.47M | $135.20M |
| QoQ Change | — | +8.9% | -3.3% | +3.4% | -4.9% | -3.6% | +29.8% | -16.5% | +1.3% | +10.1% | +9.6% | -20.0% | -0.4% | +6.6% | +9.6% | -9.5% |
| YoY Change | — | — | — | +8.8% | -5.0% | -5.2% | — | -0.6% | +5.8% | +20.9% | +2.0% | -2.2% | -3.9% | -6.9% | -6.9% | +5.2% |